3/19
10:18 am
vtvt
CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT [Yahoo! Finance]
Low
Report
CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT [Yahoo! Finance]
3/19
08:30 am
vtvt
CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT
Medium
Report
CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT
3/14
11:06 pm
vtvt
vTv Therapeutics Inc. (NASDAQ: VTVT) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Medium
Report
vTv Therapeutics Inc. (NASDAQ: VTVT) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
3/13
08:12 am
vtvt
vTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update [Yahoo! Finance]
Medium
Report
vTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update [Yahoo! Finance]
3/13
08:00 am
vtvt
vTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
Medium
Report
vTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
3/4
08:00 am
vtvt
vTv Therapeutics Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 Diabetes
High
Report
vTv Therapeutics Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 Diabetes
3/1
08:00 am
vtvt
vTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare Conference
Low
Report
vTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare Conference
2/28
08:14 am
vtvt
vTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D Fund [Yahoo! Finance]
High
Report
vTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D Fund [Yahoo! Finance]
2/28
08:00 am
vtvt
vTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D Fund
High
Report
vTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D Fund
2/22
04:11 pm
vtvt
CANTEX PHARMACEUTICALS TO PARTICIPATE IN THE BIO CEO & INVESTOR CONFERENCE [Yahoo! Finance]
Medium
Report
CANTEX PHARMACEUTICALS TO PARTICIPATE IN THE BIO CEO & INVESTOR CONFERENCE [Yahoo! Finance]
2/22
04:00 pm
vtvt
CANTEX PHARMACEUTICALS TO PARTICIPATE IN THE BIO CEO & INVESTOR CONFERENCE
Medium
Report
CANTEX PHARMACEUTICALS TO PARTICIPATE IN THE BIO CEO & INVESTOR CONFERENCE
2/21
10:23 am
vtvt
AdhereTech Announces Appointment of Paul Sekhri to Board of Directors [Yahoo! Finance]
Medium
Report
AdhereTech Announces Appointment of Paul Sekhri to Board of Directors [Yahoo! Finance]
1/30
01:05 am
vtvt
vTv Therapeutics Inc. (NASDAQ: VTVT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
vTv Therapeutics Inc. (NASDAQ: VTVT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
1/22
01:04 am
vtvt
vTv Therapeutics Inc. (NASDAQ: VTVT) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
High
Report
vTv Therapeutics Inc. (NASDAQ: VTVT) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
1/14
01:11 am
vtvt
vTv Therapeutics Inc. (NASDAQ: VTVT) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Medium
Report
vTv Therapeutics Inc. (NASDAQ: VTVT) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
1/6
01:07 am
vtvt
vTv Therapeutics Inc. (NASDAQ: VTVT) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
vTv Therapeutics Inc. (NASDAQ: VTVT) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.